Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma
J. Clin. Oncol 2020 May 26;[EPub Ahead of Print], M Roschewski, K Dunleavy, JS Abramson, BL Powell, BK Link, P Patel, PJ Bierman, D Jagadeesh, RT Mitsuyasu, D Peace, PR Watson, WT Hanna, C Melani, AN Lucas, SM Steinberg, S Pittaluga, ES Jaffe, JW Friedberg, BS Kahl, RF Little, NL Bartlett, MA Fanale, A Noy, WH WilsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.